GPT-6 Astra hits 68.7% on DrugDiscoveryBench, benchmark authors call it a step function
KexinHuang5 · x · 2026-09-16
DrugDiscoveryBench co-author afeyzaakyurek reports that GPT-6 Astra scored 68.7% on their benchmark for early-stage drug discovery computational workflows — described as a step-function jump, with Muse Spark 1.3 and Opus 5 trailing. The authors will host a talk explaining what the benchmark measures. Unverified claim pending details.
More from Models
- Open-source VoxLock tops Krisp voice isolation benchmark with 4.95% WER — Arbaz Siddiqui · 2026-11-02
- Anthropic's 85% inference margin sparks debate on open source's price-pressuring role — code_star · 2026-11-02
- User reports xAI appears to have quietly raised weekly usage limits, dropping his meter from 93% to 47% — XFreeze · 2026-11-02
- Meituan's LongCat-2.5 lands as 1.6T MoE agent model, with DeepSeek copycat speculation — teortaxesTex · 2026-11-02
- Asked what AI firms want you to stop owning, Claude said: your own compute — alex_verem · 2026-11-02
- Is Hermes Still Worth It? Codex's $200 Tier Now Overlaps Most of Its Value — Foreign_Lead_3582 · 2026-11-02